Francesco Forconi

34PUBLICATIONS
162CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|May 27, 2026
Integrated multiomic profiling reveals 2 distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

|Apr 29, 2026
Acalabrutinib monotherapy as a first-line treatment for CLL: 3-year follow-up of the real-world EPIC study.

|Apr 15, 2026
Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up.

|Apr 14, 2026
Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Clive S Zent, Enrico Tiacci, Robert J Kreitman

|Jan 20, 2026
DC-SIGN binding to the surface immunoglobulin oligomannose-type glycans promotes follicular lymphoma cell adhesion and survival.

Giorgia Chiodin, Dylan James Tatterton, Philip J Rock

|Sep 02, 2025
The origin, diagnosis, and prognosis of oligomannose-type diffuse large B-cell lymphoma.

Dylan J Tatterton, Maddy L Newby, Joel D Allen

Pageof 6

Frequent Collaborators

6 joint publications

Dean J Bryant

5 joint publications

Giorgia Chiodin

5 joint publications

Jonathan C Strefford

4 joint publications

James S Blachly